Los puntos clave no están disponibles para este artículo en este momento.
Evidence supports using antiplatelet therapy in patients with acute ischemic stroke. However, neurological deterioration remains common under the currently recommended antiplatelet regimen, leading to poor clinical outcomes.
Zhao et al. (Mon,) studied this question.